Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Oncology

Diagnostics Digital and computational pathology

Biosensors for the Future

| Luke Turner

From a new material for lung cancer diagnosis to real-time robotics for monitoring reproductive hormones, discover our latest bite-sized breakthroughs

Subspecialties Biochemistry and molecular biology

Jagged Little Pill (for Cancer)

| Luke Turner

A Jagged protein directly linked to cancer metastasis could be targeted to assess the aggressiveness of tumors and prevent their rapid spread

Inside the Lab Clinical care

Positive Steps to Tackle Triple-Negative Breast Cancer

| Jane Armes

Jane Armes discusses the value of molecular subtyping and targeted therapies in triple-negative breast cancer

Inside the Lab Biochemistry and molecular biology

A Fluid Future

| Luke Turner

Liquid biopsy has shown promise as a rapid, minimally invasive way to profile tumors – but are commercially available tests accurate and consistent?

Diagnostics Liquid biopsy

A Diagnostic to Drool Over?

| Luke Turner

The use of saliva as a diagnostic fluid seems an attractive option – especially now that research reveals circulating tumor DNA in the fluid

Diagnostics Genetics and epigenetics

Scrutinizing Breast Cancer

| Michael Schubert

The FLEX breast cancer registry intends to collect complete information on 10,000 patients over the course of 10 years

Outside the Lab Profession

Lessons Learned, with Andrew Feinberg

| Andrew Feinberg

A pioneer of epigenetics discusses his career and what he has learned from a fascinating journey through medicine

Diagnostics Biochemistry and molecular biology

Treat or Surveil

| George Vasmatzis and John Cheville

Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients

Diagnostics Clinical care

MDLUX2: Drawing a Fuller Picture

| Michael Schubert

Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care

Inside the Lab Liquid biopsy

Building a Better Biopsy

| Lisa M. Wright

To harness liquid biopsy’s many advantages, it’s vital to ensure appropriate testing – and cfDNA synthetic plasma reference standards can help

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register